Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ming Y.W. Chu"'
Autor:
Lorrin K Yee, Paul Calabresi, Milton H. Lipsky, Katharine A. Whartenby, Ming Y.W. Chu, Edwin N. Forman, Edward Chu, John Epstein, Scott M. Freeman, Tian M. Chen
Publikováno v:
Pharmacology. 56:318-326
An in vivo experimental model was developed to predict efficiently and accurately chemosensitivity of human tumors. Human cancer cells either from cultured cell lines or from patients’ tumors were injected directly into semipermeable polysulfone fi
Autor:
TianM Chen, Robert M. Levin, David Russel, Harry J. Wilbur, Robin De Wolf, Tracey Fletcher, Paul Calabresi, Ming Y.W. Chu, Shailendra Kumar, Miklos Gellai, John Zalcberg, Laura J. Mogavero, Mel H. Epstein, Milton H. Lipsky, Hemendra N. Bhargava, Gail G. Snitkoff, Wei-zheng. Zhang, Paul W. Finch, Walter Cosolo, Tamar J. Nicholas, Lorrin K Yee, Thomas Maciag, Ponnal Nambi, Stanley Friedman, Hyung-Min Kim, James Mandell
Publikováno v:
Pharmacology. 55:I-IV
Autor:
Milton H. Lipsky, Paul Calabresi, Ming Y.W. Chu, Thomas Maciag, TianM Chen, Lorrin K Yee, Mel H. Epstein, Paul W. Finch, Stanley Friedman
Publikováno v:
Pharmacology. 55:269-278
Interference with growth factor-receptor interactions may have particular relevance in efforts to intervene clinically in both autocrine and paracrine aspects of malignancy. Suramin is a synthetic anticancer agent that works, in part, by blocking the
Autor:
Robert M. Levin, Robin De Wolf, Laura J. Mogavero, Hemendra N. Bhargava, James Mandell, Tracey Fletcher, Tamar J. Nicholas, Paul Calabresi, Lorrin K Yee, Hyung-Min Kim, TianM Chen, Stanley Friedman, Mel H. Epstein, Harry J. Wilbur, Walter Cosolo, Thomas Maciag, John Zalcberg, Miklos Gellai, Paul W. Finch, Ponnal Nambi, Gail G. Snitkoff, Wei-zheng. Zhang, Ming Y.W. Chu, Milton H. Lipsky, David Russel, Shailendra Kumar
Publikováno v:
Pharmacology. 55:319-322
Autor:
Edward Chu, Ming Y.W. Chu, Bai Chuan Pan, Paul Calabresi, Shih Hsi Chu, Lorrin K Yee, Michael H. Lipsky, Tian Min Chen
Publikováno v:
Pharmacology. 56(2)
At a nontoxic growth inhibitory concentration benzyloxyacyclouridine (BAU), a potent and specific inhibitor of uridine phosphorylase (UrdPase), enhanced 5-fluorouracil (5-FU) cytotoxic activity against human prostate cancer PC-3 and DU-145 cell lines
Autor:
Ming Y.W. Chu, G., Lipsky, Milton H., Yee, Lorrin K., Epstein, John, Whartenby, Katharine A., Freeman, Scott, Chu, Edward, Forman, Edwin N., Calabresi, Paul, Chen, Tian M.
Publikováno v:
Pharmacology; Jun98, Vol. 56 Issue 6, p318-326, 9p, 6 Graphs